(GLMD) - Earnings & Price History

GLMD: - 8.04, $99.95M, -0.16 (-1.95%)

Sector: Healthcare - Industry: Biotechnology

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of a once-daily, oral therapy for the treatment of liver diseases. It is developing Aramchol, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.Key Statistics

Past GLMD reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-22-0.34.644.634.74.64.751.51%-1.28%0.22%8.52K
2017-03-21-0.34.634.784.734.624.78-1.05%-2.11%-3.14%31.54K
2017-03-20-0.34.785.015.24.685.383.79%-8.08%-4.59%95.33K
2016-11-07-0.393.433.193.423.193.447.21%▲0.29%7.52%76.82K
2016-08-03-0.354.244.134.124.094.3-0.24%2.91%2.66%1.72K
2016-05-16-0.335.295.385.465.045.51.49%-3.11%-1.67%11.77K
2016-05-13-0.33
2016-03-22-0.284.074.464.464.074.48-8.74%-8.74%16.10K
2015-11-09-0.299.7559.819.448.749.755-3.77%▲3.34%-0.56%31.65K
2015-08-13-0.259.189.15999.45-1.64%2.00%0.33%16.87K
2015-05-13-0.368.418.258.678.288.75.09%-3.00%1.94%16.33K
2015-03-31-0.368.879.429.58.729.540.85%-6.63%-5.84%70.07K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades